Perspective Therapeutics, Inc. · Brief

Next report

7 days

Nov 9 · after closeest.Q3 FY26

Expected move

No implied move.

8 reportsHistory

0 of 6≥ implied

Mar 26 '25—▲+1.32%—

May 12 '25—▲+1.59%—

Aug 13 '25±58.5%▼−4.27%×0.07

Q3 FY25±22.6%0.00%×0.00

Jan 9 '26±87.1%▲+1.07%×0.01

Q1 FY26±10.4%▼−5.17%×0.50

May 11 '26±85.0%▼−2.84%×0.03

Q2 FY26±21.1%▲+6.00%×0.28

quarterimplied−90%0+90%realized×

Q2 FY26±21.1%▲+6.00%×0.28

May '26±85.0%▼−2.84%×0.03

Q1 FY26±10.4%▼−5.17%×0.50

Jan '26±87.1%▲+1.07%×0.01

Q3 FY25±22.6%0.00%×0.00

Aug '25±58.5%▼−4.27%×0.07

2 older reports

May '25—▲+1.59%—

Mar '25—▲+1.32%—

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Nov 9 report · est.

Bull2 of 3

128managers reporting a position in the latest quarterly filings13F · Jun 30 '26

+8.48%change in shares held by the ten largest reporting managers over the latest quarter13F · Jun 30 '26

Bear2 of 4

6 of 6recent reports where the move came in under the options implied rangeEarnings history

0.13%of State Street SPDR S&P Biotech ETF's assets, the largest tracked-fund weightN-PORT · Jun 30 '26

AI captions · Sep 28 '26once per report · top 2 per case

CATX report session

No linked exposure.

Oct 23haltTrading halt: 08:12 ET, resumed 11:05 ET.Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.